Successful treatment of adult Langerhans cell histiocytosis with intensified chemotherapy

International Journal of Hematology
Mariko MinamiKoichi Akashi

Abstract

Langerhans cell histiocytosis (LCH) is a rare disease in adults. The treatment strategy for this condition remains controversial. Intensified systemic chemotherapy is required in pediatric patients with the multiple system form of LCH (MS-LCH) for aggressive forms of the disease. Recent clinical trials have shown that intensified chemotherapy for pediatric patients diagnosed with MS-LCH results in improved outcomes. However, whether the feasibility and efficacy of an intensified systemic chemotherapy regimen are also beneficial for adult patients with MS-LCH remains unclear. Here, we report two cases of adult MS-LCH that were successfully treated with an intensified treatment protocol as used in pediatric patients. One patient fully completed the protocol, and has since maintained a complete response (CR) for 2 years following completion of the treatment. The other patient also achieved CR after induction therapy, and is now undergoing maintenance therapy in an outpatient clinic. The cases presented in this study suggest that intensified systemic chemotherapy as used for pediatric patients with MS-LCH is well tolerated and effective for adult patients as well.

References

Jul 15, 1999·Clinical and Experimental Immunology·L MiseryC Vincent
May 9, 2001·The Journal of Pediatrics·H GadnerUNKNOWN Histiocyte Society
Oct 12, 2002·Medical and Pediatric Oncology·Milen MinkovUNKNOWN DAL-HX Study Group
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M AricòC Danesino
Mar 22, 2006·European Journal of Haematology·Marcus Stockschlaeder, Christoph Sucker
Jun 26, 2008·Pediatric Dermatology·Elizabeth K Satter, Whitney A High
Sep 26, 2009·International Journal of Hematology·Shinsaku ImashukuUNKNOWN Japan LCH Study Group
Mar 12, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carl E AllenKenneth L McClain
Jun 4, 2010·Blood·Gayane Badalian-VeryBarrett J Rollins
Oct 22, 2011·International Journal of Hematology·Shinsaku ImashukuAkira Morimoto
Oct 25, 2011·British Journal of Haematology·Gayane Badalian-VeryBarrett J Rollins
May 16, 2013·Orphanet Journal of Rare Diseases·Michael GirschikofskyKenneth L McClain
Mar 19, 2014·The Journal of Experimental Medicine·Marie-Luise BerresCarl E Allen
Jun 5, 2014·Blood·Christine Delprat, Maurizio Aricò

❮ Previous
Next ❯

Citations

Oct 16, 2015·Hematology/oncology Clinics of North America·Chalinee Monsereenusorn, Carlos Rodriguez-Galindo
Feb 28, 2020·Blood·Carlos Rodriguez-Galindo, Carl E Allen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.